Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
Epilepsy Currents|August 22, 2020
Treatment of Refractory Convulsive Status Epilepticus: A Comprehensive Review by the American Epilepsy Society Treatments CommitteeDavid G Vossler, Jacquelyn L Bainbridge, Jane G Boggs, et al.
Epilepsy & Behavior : E&B|July 6, 2024
Brivaracetam effectiveness and tolerability in older and younger adults with epilepsy: EXPERIENCE, a pooled analysis of international data from retrospective studiesEdward Faught, Hervé Besson, Wendyl D'Souza, et al.
Journal of Neurology|March 4, 2024
Effectiveness and tolerability of brivaracetam in patients with epilepsy stratified by comorbidities and etiology in the real world: 12-month subgroup data from the international EXPERIENCE pooled analysisJerzy P Szaflarski, Hervé Besson, Wendyl D'Souza, et al.
Neurology|September 15, 2021
Safety and Efficacy of Natalizumab as Adjunctive Therapy for People With Drug-Resistant Epilepsy: A Phase 2 StudyJacqueline A French, Andrew J Cole, Edward Faught, et al.
CNS Drugs|September 8, 2023
Effectiveness and Tolerability of 12-Month Brivaracetam in the Real World: EXPERIENCE, an International Pooled Analysis of Individual Patient RecordsVicente Villanueva, Cédric Laloyaux, Wendyl D'Souza, et al.
Frontiers in Neurology|December 27, 2021
Superior Verbal Memory Outcome After Stereotactic Laser AmygdalohippocampotomyDaniel L Drane, Jon T Willie, Nigel P Pedersen, et al.
Epilepsia|October 6, 2017
Detection of generalized tonic-clonic seizures using surface electromyographic monitoringJonathan J Halford, Michael R Sperling, Dileep R Nair, et al.
Epilepsy & Behavior : E&B|August 8, 2025
Immediate-use rescue medication and the epilepsy monitoring unit: experiences from an expert panelEvelyn K Shih, Brin E Freund, Michael R Sperling, et al.
Epilepsia|April 23, 2004
Efficacy and tolerability of the new antiepileptic drugs, I: Treatment of new-onset epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy SocietyJacqueline A French, Andres M Kanner, Jocelyn Bautista, et al.
Epilepsia|April 23, 2004
Efficacy and tolerability of the new antiepileptic drugs, II: Treatment of refractory epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy SocietyJacqueline A French, Andres M Kanner, Jocelyn Bautista, et al.
Pageof 12